Literature DB >> 667942

Variability in the amount of beta-globin mRNA in beta0 thalassemia.

E J Benz, B G Forget, D G Hillman, M Cohen-Solal, J Pritchard, C Cavallesco, W Prensky, D Housman.   

Abstract

Globin mRNA isolated from a number of beta0 thalassemia patients of different ethnic origins was analyzed by RNA-cDNA hybridization and, in two cases, by fingerprint analysis of 125I-labeled mRNA. Quantitation of the relative amounts of alpha- and beta-mRNA by hybridization to purified alpha-and beta-cDNA revealed that in approximately half the cases, there was less than 1% as much beta-mRNA as alpha-mRNA. In the rest of the cases, low levels of beta-like mRNA were detected in amounts 4-12% as abundant as alpha-mRNA. There was variability in the yield of beta-like mRNA in patients of the same racial group, in the same patient at different times and in similarly affected siblings: beta-mRNA was virtually absent in some samples, whereas low but significant levels were found in other samples. In one patient, beta-like mRNA was not detected in peripheral blood RNA, but was present in the RNA of bone marrow cells. In one case, the thermal stability of the beta0 thalassemia mRNA-beta-cDNA hybrid was measured and found to be slightly lower than that of the authentic beta-mRNA-beta-cDNA hybrid. In none of the cases tested was there synthesis of beta-globin chains directed by beta0 thalassemia mRNA in a cell-free protein-synthesizing system, even when beta-like mRNA was detected in the sample by hybridization assays. mRNA from two patients was labeled in vitro with 125I, digested with T1 RNAase and fractionated in two dimensions. Analysis of the resulting fingerprints revealed the presence of prominent alpha chain-specific oligonucleotides without detectable beta chain-specific oligonucleotides, and thereby confirmed the results of hybridization assays showing absent or very low levels of beta-mRNA in the same RNA samples. Our results support the concept that beta0 thalassemia is heterogeneous in its molecular basis even within the same racial group: in some patients, it is associated with absent beta globin mRNA, whereas in other patients, it is associated with low but significant levels of nonfunctional beta or beta-like globin mRNA. The variable amounts of beta-like mRNA detected in different samples from the same patient, and in patients with the same genotype, indicate that as yet undefined factors can influence the yield of beta-like mRNA observed in beta0 thalassemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667942     DOI: 10.1016/0092-8674(78)90116-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  22 in total

1.  beta (+)-Thalassaemia in the Po river delta region (northern Italy): genotype and beta globin synthesis.

Authors:  L Del Senno; M Pirastu; R Barbieri; F Bernardi; D Buzzoni; G Marchetti; C Perrotta; C Vullo; Y W Kan; F Conconi
Journal:  J Med Genet       Date:  1985-02       Impact factor: 6.318

2.  The structure of the human beta-globin gene in beta-thalassaemia.

Authors:  R A Flavell; R Bernards; J M Kooter; E de Boer; P F Little; G Annison; R Williamson
Journal:  Nucleic Acids Res       Date:  1979-06-25       Impact factor: 16.971

3.  beta-Thalassemia present in cis to a new beta-chain structural variant, Hb Vicksburg [beta 75 (E19)Leu leads to 0].

Authors:  J G Adams; M H Steinberg; M V Newman; W T Morrison; E J Benz; R Iyer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

4.  An intron nucleotide sequence variant in a cloned beta +-thalassaemia globin gene.

Authors:  D Westaway; R Williamson
Journal:  Nucleic Acids Res       Date:  1981-04-24       Impact factor: 16.971

Review 5.  The thalassemias: molecular mechanisms of human genetic disease.

Authors:  R A Spritz; B G Forget
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

6.  Embryonic-fetal erythroid characteristics of a human leukemic cell line.

Authors:  E J Benz; M J Murnane; B L Tonkonow; B W Berman; E M Mazur; C Cavallesco; T Jenko; E L Snyder; B G Forget; R Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

7.  Posttranscriptional defects in beta-globin messenger RNA metabolism in beta-thalassemia: abnormal accumulation of beta-messenger RNA precursor sequences.

Authors:  E J Benz; A L Scarpa; B L Tonkonow; H A Pearson; A K Ritchey
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

8.  Physicochemical measurement of the base composition of mRNA-related sequences of the human alpha and beta globin genes.

Authors:  D Tuan; B G Forget
Journal:  Mol Biol Rep       Date:  1980-10-31       Impact factor: 2.316

9.  Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.

Authors:  T Ariga; T Igarashi; N Ramesh; R Parad; M Cicardi; A E Davis
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

10.  Molecular analysis of the beta-thalassemia phenotype associated with inheritance of hemoglobin E (alpha 2 beta2(26)Glu leads to Lys).

Authors:  E J Benz; B W Berman; B L Tonkonow; E Coupal; T Coates; L A Boxer; A Altman; J G Adams
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.